Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2012; 18(31): 4150-4155
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4150
Table 2 Bilirubin, CA19-9 and C-reactive protein levels according to jaundice cause at time of hospital admission n (%)
CauseNo. of casesBilirubin(g/dL), medianCA19-9 (U/mL)
CRP (U/mL)
MedianP value1> 32> 100MedianP value2> 1.5> 5
Malignant519.740542 (8.3)35 (68.6)225 (49)7 (13.7)
Pancreatic cancer25 (49)11.29461-23 (92)19 (76)1.960.0412 (48)3 (12)
Bile duct cancer10 (19.6)9.943130.287 (70)6 (60)1.260.061 (10)0
Gallbladder cancer7 (13.7)8.9433610.596 (85.7)5 (71.4)4.13a0.915 (71.4)2 (28.5)
Ampullary cancer5 (9.8)6.491960.424 (80)3 (60)4.50.694 (80)1 (0.2)
Intrahepatic cholangio carcinoma1 (1.9)16.132600NA115.96NA11
Others3 (5.8)7.65160.53114.950.842 (66.6)1 (33.3)
Benign515.23628 (54.9)18 (35.3)4.534 (66.6)21 (41.2)
CBD stones34 (66.6)5.63420.1019 (55.8)12 (35.2)3.47-22 (64.7)11 (32.3)
Gallbladder stones with cholangitis8 (15.7)5.26550.544 (50)3 (37.5)2.310.735 (62.5)3 (37.5)
Biliary pancreatitis8 (15.7)3.85610.274 (50)3 (37.5)10.330.047 (87.5)7 (87.5)
Chronic papillitis1 (1.9)6.635NA100.7NA00